News
FDA Approves Nonstimulant Liquid Onyda XR for ADHD
The once-daily extended-release oral suspension, with nighttime dosing, can be used alone or as an adjunctive therapy to FDA-approved stimulant...
News
Is Mental Illness ‘Transmissible’?
Teens whose classmates have mental illnesses are 3% more likely to later receive a psychiatric diagnosis, study finds.
News
First US Adult ADHD Guidelines Finally on the Way?
ADHD is the second-most common psychiatric disorder in adults but mental health professionals report a lack of familiarity with the disorder in...
News
Androgenetic Alopecia: Study Finds Efficacy of Topical and Oral Minoxidil Similar
A randomized, controlled, blinded study finds little difference between the two forms of the drug in promoting hair growth in men.
News
Physicians Received $12 Billion from Drug, Device Makers in Less Than 10 Years
Industry payments appeared to have been little changed by public reporting in the Open Payments database.
News
Florida Legislature Passes Free Skin Cancer Screening Requirement
The Florida legislation will allow physician assistants and advanced practice nurses who operate under the supervision of a dermatologist to...
News
FDA Issues New Guidance for Early Alzheimer’s Drug Development
The FDA noted that a key principle in developing guidance for early Alzheimer’s disease therapies is that treatment “must begin before there are...
News
No End in Sight for National ADHD Drug Shortage
Adderall has been in short supply for a year and half due to several causes, which have not yet been resolved.
News
Alzheimer’s Research Has an Integrity Problem, Claim Investigators
Questions about the validity of some Alzheimer’s research has potentially slowed progress in treatment of the disease.
News
Opioid Epidemic ‘Fourth Wave’ Marked by Methamphetamine Use
The use of methamphetamine by people who also use fentanyl reached a record high in 2023.
News
Study: Lifetime Cost of Vyjuvek Gene Therapy for DEB Could Be $15-$22 Million
"The wider indication granted by the FDA may lead to friction between payers on the one hand and patients and physicians on the other," the...
News
New Tools on the Horizon for Managing cSCC in Solid Organ Transplant Recipients
Immune checkpoint inhibitors offer promise but organ rejection still a major concern with their use.
News
FDA Recommends DEA Move Cannabis From Schedule I to III
The FDA said in its report that cannabis is a low-risk threat to public health.
News
‘Fake Xanax’ Tied to Seizures, Coma Is Resistant to Naloxone
Bromazolam is one of at least a dozen designer benzodiazepines created in the lab but not approved for any therapeutic use.
News
Pediatric Obesity Specialists Struggle to Get GLP-1s
Both liraglutide and semaglutide “are largely unavailable or quite hard to get a hold of.”